Semin Musculoskelet Radiol 2007; 11(4): 281-300
DOI: 10.1055/s-2008-1060332
© Thieme Medical Publishers

Scintigraphy of Benign Bone Disease

Hans Van der Wall1 , Ignac Fogelman2
  • 1Department of Nuclear Medicine, Concord Hospital, Sydney, Australia
  • 2Division of Imaging, King's College, London, United Kingdom
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
07. März 2008 (online)

Preview

ABSTRACT

Bone scintigraphy is ideally suited for the investigation of benign bone disease as it functions at a physiological level. It is freely available and has whole-body capability and high-contrast resolution. When coupled with single-photon emission computed tomography/computed tomography (SPECT/CT), it can be utilized to provide precise anatomical localization, attenuation correction, and therefore better lesion localization. A considerable volume of data has accumulated on the role of bone scintigraphy in trauma and its complications, overuse injuries, vascular disease of bone, metabolic bone diseases, and a variety of other disorders. This article is an overview of the established applications and signposts of potential future applications with the increasing prevalence of SPECT/CT devices and technical advances in attenuation correction, collimator modeling, and resolution recovery software.

REFERENCES

Dr. Hans Van der Wall

Department of Nuclear Medicine, Concord Hospital, Hospital Rd.

Concord 2139, Australia

eMail: hansv@nmrf.org.au